Symeres

We blend the art of formulation with advanced scientific tools to support drug product development from early stages through Phase 3, offering comprehensive manufacturing and regulatory services. It is often said that formulation is an art, not a science. Our art is supported by an extensive array of scie...

Close collaboration with our experienced process engineers aid our efforts achieve right first time scale-up of processes for GMP manufacture. The processes developed at our facilities are adapted to the plant environment in close collaboration with experienced process engineers. The limits of operating c...

Symeres has long-established expertise in non-GMP scale-up for IND-enabling studies, ensuring that our clients can confidently navigate the transition from laboratory-scale synthesis to clinical phases while minimizing costs and risks. The well-documented processes we provide significantly reduce the inh...

Symeres is well equipped to ideate around your challenging small molecule APIs

Our Solid-State experts can help you to selectively crystallize the optimal stable form and formulate your compound. A controlled crystallization is the preferred isolation method to obtain purified material of a specific polymorphic (salt) form and crystal habit. The solid form determines the stability, ...

Symeres can design, scale-up and manufacture novel lipids and small molecule APIs for wide variety of clients: small biotechs to large Pharma organizations

Symeres can upscale and manufacture novel APIs 

Leverage our 30+ years of experience to design your optimal drug route, with seamless transition to our non-GMP or GMP scale-up units.

Our Solid-State experts can help you to selectively crystallize the optimal stable form and formulate your compound.

A controlled crystallization is the preferred isolation method to obtain purified material of a specific polymorphic (salt) form and crystal habit. The solid form determines the stability, solubility and permeability of the compound; therefore, the selection of a pharmaceutically suitable form will manage the risks in further development. The pre-formulation experts study excipient compatibility, pH-dependent solubility and dissolution rate optimization to improve the bioavailability. Symeres has performed hundreds of form characterization and selection screens on innovative APIs throughout the years.